英文别名: |
valeramide;N-VALERAMIDE;PENTANAMIDE;VALOYLAMINE;Pentanimidic acid;n-Pentanamid;n-pentyl amide;pentaneamide;pentylamide;TKL9TN43QK;IPWFJLQDVFKJDU-UHFFFAOYSA-N;Valeramide, 97%;Valeric acid amide;Pentanamide (Valeramide);KSC353I5P;IPWFJLQDVFKJDU-UHFFFAOYSA-;STL283920;NSC400223;7330AF;LMFA08010002;SBB028169;NE22996;SCHEMBL20284;V0002;NS00035130;CHEBI:16459;FS-4458;UNII-TKL9TN43QK;AKOS009031546;MFCD00041895;C01842;NSC 400223;A833929;DTXSID3060827;EN300-19981;CH3(CH2)3C(O)NH2;AI3-24387;Valeramide;CS-0206049;FT-0603495;Valeramide, pharmaceutical impurity standard;Q6071464;InChI=1/C5H11NO/c1-2-3-4-5(6)7/h2-4H2,1H3,(H2,6,7);Z104476278;626-97-1;EINECS 210-974-0;Pentanamide;Pentanamide; Valproic Acid Imp. E (EP); Valeramide; Valproic Acid Impurity E;NSC-400223;VALPROIC ACID IMPURITY E [EP IMPURITY];Valproic Acid Imp. E (EP): Pentanamide (Valeraide) |